Androgen in the treatment of osteoporosis
Tanaka, S.; Haji, M.; Nawata, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 365-372
2002
ISSN/ISBN: 0047-1852 PMID: 11979931 Document Number: 545612
Document emailed within 1 workday
Related Documents
Roux, C. 2003: Osteoporosis due to androgen suppression therapy in men with prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(2 Suppl 1: 24-27Yanase, T. 2016: A potential of selective androgen receptor modulator(SARM)for the therapy of osteoporosis Clinical Calcium 26(7): 1023-1030
Spanjol, J.; Maricić, A.; Valencić, M.; Oguić, R.; Krpina, K.; Protić, A.; Ivancić, A.; Bobinac, M.; Fuckar, D.; Vojniković, B. 2008: Influence of insolation on osteoporosis progression in androgen deprived nonmetastatic prostate cancer patients Collegium Antropologicum 32(Suppl 2): 79-81
Pettaway, C.A. 1999: Racial differences in the androgen/androgen receptor pathway in prostate cancer Journal of the National Medical Association 91(12): 653-660
Yen, J-Lung.; Chang, K-Huey.; Sheu, J-Cherng.; Lee, Y-Jinn.; Tsai, L-Ping. 2005: Partial androgen insensitivity syndrome with R840H mutation in androgen receptor: report of one case Acta Paediatrica Taiwanica 46(2): 101-105
Bastos, D.A.; Dzik, C.; Rathkopf, D.; Scher, H.I. 2014: Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer Oncology 28(8): 693-699
Izbicka, E.; MacDonald, J.R.; Davidson, K.; Lawrence, R.A.; Gomez, L.; Von Hoff, D.D. 1999: 5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells Anticancer Research 19(2a): 1285-1291
Nickel, B.; Schwartz, A.; Rosenmann, E.; Kaufman, M.; Pinsky, L.; Wrogemann, K. 1988: A study of androgen-resistant subjects indicates that the 6.7 pI/56 kDa protein in genital skin fibroblasts is related to the androgen receptor Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 22-33
Sultan, C. 1986: Androgen receptors and partial androgen insensitivity in male pseudohermaphroditism Annales de Genetique 29(1): 5-10
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319
Barats, S.S.; Iordanidi, S.A. 1973: Androgen excretion in men in angina pectoris and cardialgia and changes in lipoprotein metabolism and in the blood coagulation system in androgen deficiency Kardiologiia 13(8): 74-77
Lumbroso, S.; Lobaccaro, J.M.; Belon, C.; Amram, S.; Rodier, M.; Bringer, J.; Sultan, C. 1993: Familial form of partial androgen insensitivity (Reifenstein syndrome): arginine-histidine mutation in position 840 in the androgen receptor Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 187(4): 508-515
Amler, L.C.; Agus, D.B.; LeDuc, C.; Sapinoso, M.L.; Fox, W.D.; Kern, S.; Lee, D.; Wang, V.; Leysens, M.; Higgins, B.; Martin, J.; Gerald, W.; Dracopoli, N.; Cordon-Cardo, C.; Scher, H.I.; Hampton, G.M. 2000: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1 Cancer Research 60(21): 6134-6141
Chinoy, M.R.; Chinoy, N.J. 1983: Differential androgen requirements of proximal and distal vas deferens of albino rats and possible potentiation of androgen action by ascorbic acid Indian Journal of Experimental Biology 21(6): 335-338
Gu, Y.; Kim, K-Hong.; Ko, D.; Srivastava, S.; Moul, J.W.; McLeod, D.G.; Rhim, J.S. 2005: Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line Anticancer Research 25(1a): 1-8
Lobaccaro, J.M.; Lumbroso, S.; Sultan, C. 1991: Androgen receptor gene polymorphism analysis: application to screening of heterozygote and to prenatal diagnosis of androgen insensitivity syndrome Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 185(6): 422-433
Chinta, G.; Ramya Chandar Charles, M.; Klopčič, I.; Sollner Dolenc, M.; Periyasamy, L.; Selvaraj Coumar, M. 2015: In Silico and in Vitro Investigation of the Piperine's Male Contraceptive Effect: Docking and Molecular Dynamics Simulation Studies in Androgen-Binding Protein and Androgen Receptor Planta Medica 81(10): 804-812
Gao, J.; Isaacs, J.T. 1998: Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells Cancer Research 58(15): 3299-3306
Pino, A.M. 1996: Androgen receptor gene structure and protein function. Gene structural defects that promote androgen resistance in men Revista Medica de Chile 124(9): 1127-1136
Jarrard, D.F.; Kinoshita, H.; Shi, Y.; Sandefur, C.; Hoff, D.; Meisner, L.F.; Chang, C.; Herman, J.G.; Isaacs, W.B.; Nassif, N. 1998: Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells Cancer Research 58(23): 5310-5314